A PYMNTS Company

Morgan Stanley Capital to Sell Pathway Vet for $2B

By  |  March 15, 2020

Morgan Stanley Capital Partners agreed to sell veterinary clinic chain Pathway Vet Alliance LLC to TSG Consumer Partners in a deal worth at least $2 billion, including debt, reported the Wall Street Journal.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The private-equity arm of Morgan Stanley Investment Management bought a stake in Pathway Vet in 2016 and expanded its operations through acquisitions. Further details of the deal weren’t available and it’s unclear how much debt TSG plans to use to finance the transaction, according to Dow Jones.

    Pet owners in the US are expected to spend nearly $100 billion on their pets this year on everything from pet food to toys, an increase of around $5 billion on last year, according to research produced by the American Pet Products Association. Nearly a third of this expenditure is estimated to go toward paying vet bills, the research shows.

    These trends have attracted large companies to the sector, including Mars Inc., best known for its candy bars, and consumer-focused investor JAB Holding  which owns Krispy Kreme doughnuts.

    Last year, for example, JAB bought a stake in Compassion-First Pet Hospitals, a chain of US vet clinics, in a $1.22 billion deal. Mars bought pet health business AniCura Holding AB for close to €2 billion the year before.

    Full Content: Wall Street Journal

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.